1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(10-PHENYL)-DECANIMIDE
Compound with spectra: 1 NMR
![1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(10-PHENYL)-DECANIMIDE](/api/compound/IB3RYJQxKWU.png?ph=true&h=300&w=458 "1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(10-PHENYL)-DECANIMIDE")
| SpectraBase Compound ID | IB3RYJQxKWU |
|---|---|
| InChI | InChI=1S/C34H42ClN5O/c1-40(38-33(41)19-11-6-4-2-3-5-8-14-27-15-9-7-10-16-27)24-22-39(23-25-40)34-29-17-12-13-18-30(29)36-31-21-20-28(35)26-32(31)37-34/h7,9-10,12-13,15-18,20-21,26,36H,2-6,8,11,14,19,22-25H2,1H3 |
| InChIKey | IDDUJTCUODEMSP-UHFFFAOYSA-N |
| Mol Weight | 572.2 g/mol |
| Molecular Formula | C34H42ClN5O |
| Exact Mass | 571.307789 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(8-PHENYL)-OCTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-2-(PHENYL)-ACETIMIDE
Clozapine-M (7 OH)
JHU37160
Clozapine-M (6 OH)
Clozapine ME
(12-N-Methyl)-11-(o-methylaniline)-5H-dibenzo[b,e][1,4]diazepines
| Title | Journal or Book | Year |
|---|---|---|
| Aminimides as Potential CNS Acting Agents. II Design, Synthesis, and Receptor Binding of 4′-Arylalkyl Aminimide Analogues of Clozapine as Prospective Novel Antipsychotics | Australian Journal of Chemistry | 2008 |